TGA Approval

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297931)

ARTG ID

297931

ARTG Name

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack

Sponsor

Hetero Australia Pty Ltd

ARTG Date

December 13, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

HETERO AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/19be25573db4ef9f8ec0750b1434d4b6.pdf

Ingredient Name

abacavir sulfate

Ingredient Name

lamivudine

Empowering clinical research with data-driven insights and AI-powered tools.

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297931) - TGA 批准文号 | MedPath